Jason Lim
Direktor/Vorstandsmitglied bei Orum Therapeutics USA, Inc.
Ursprung des Netzwerks ersten Grades von Jason Lim
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Orum Therapeutics USA, Inc.
Orum Therapeutics USA, Inc. BiotechnologyHealth Technology Part of Orum Therapeutics, Inc., Orum Therapeutics USA, Inc. is a biotechnology company that develops tumor-directed targeted protein degraders. The company is based in Cambridge, MA. The company was founded in 2016 by Sung Joo Lee. Sung Joo Lee has been the CEO since 2016.
3
| Subsidiary | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jason Lim
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of British Columbia | College/University | Masters Business Admin | |
BC Biotech
BC Biotech Investment Trusts/Mutual FundsMiscellaneous BC Biotech is a Canadian biotechnology company that works in the field of applied biology, using engineering, medicine, and technology in conjunction with living organisms and bioprocesses. BC Biotech also provides information on how to study biotechnology in school and which institutions are known for their program. The non-profit company is based in Vancouver, Canada. The company aims to promote businesses in the biotechnology industry and inform people about the science behind it. | Investment Trusts/Mutual Funds | Chairman | |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Chairman | |
ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Discovery Parks Trust | Director/Board Member | ||
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Financial Conglomerates | Chairman | |
Aquinox Pharmaceuticals (Canada), Inc.
Aquinox Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals (Canada), Inc. manufactures pharmaceuticals for blood caner treatment. The company is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Chief Executive Officer | |
Orum Therapeutics, Inc.
Orum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Orum Therapeutics, Inc. operates as a biotechnology company which operates cell-penetrating antibody platform. The firm leverages its cell penetrating antibody platform to inhibit drug targets undruggable by small molecule or current antibody therapeutics. The company was founded by Seung-Ju Lee and Yong-Sung Kim on August 17, 2016 and is headquartered in Daejeon, South Korea. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Kanada | 13 |
Vereinigte Staaten | 4 |
Südkorea | 2 |
Sektoral
Health Technology | 10 |
Commercial Services | 4 |
Consumer Services | 2 |
Miscellaneous | 2 |
Finance | 2 |
Operativ
Director/Board Member | 7 |
President | 6 |
Chief Executive Officer | 5 |
Chairman | 5 |
Founder | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David Main | 17 |
Sung Joo Lee | 1 |
Yeo Jung Moon | 1 |